Content on this page:
Content on this page:
Overview
Dengue has been endemic in
Southeast Asia in the past years. The Introduction
section tells the course of the disease, while details on the incidence and
mortality rates in Asia are in the Epidemiology
section.
Transmission of dengue through the bite of the Aedes
mosquito, the incubation period and the different serotypes have been discussed
in the Pathophysiology section.
Dengue_Disease SummaryConditions that increase the likelihood of developing severe dengue are enumerated in the Risk Factors section. The World Health Organization (WHO) 2009 classification of Dengue as well as the old classification has been discussed in the Classification section.
History and Physical Examination
There are three phases of dengue infection and in the Clinical Presentation section, the signs and symptoms of these phases are discussed.
Diagnosis
Several tests that can be done to diagnose dengue are
enumerated and discussed in the Laboratory
Tests and Ancillaries section.
Other conditions which present with a syndrome
similar to dengue have to be ruled out and these are listed in the Differential Diagnosis section.
Management
The criteria for home management, hospitalization and
emergency treatment of patients infected with the dengue virus are in the Evaluation section, while symptomatic and
supportive therapies, including fluid replacement therapy and blood
transfusion, are discussed in the Pharmacological
Therapy and Nonpharmacological sections.
Dengue infection can be prevented through different methods
of vector control and by vaccination that are in detailed in the Prevention section.
Continuous tracking of patient’s status, particularly those with
shock, and the effectiveness of treatment are discussed in the Monitoring section.
Hemorrhagic complications, fluid overload and
other complications of dengue infection are presented in the Complications section.
